Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Central nervous system and limb anomalies in case reports of first-trimester statin exposure.

Edison RJ, Muenke M.

N Engl J Med. 2004 Apr 8;350(15):1579-82. No abstract available. Erratum in: N Engl J Med. 2005 Jun 30;352(26):2759.

2.

Terminal transverse limb defects with tethering and omphalocele in a 17 week fetus following first trimester misoprostol exposure.

Genest DR, Di Salvo D, Rosenblatt MJ, Holmes LB.

Clin Dysmorphol. 1999 Jan;8(1):53-8. Review.

PMID:
10327252
4.

Developmental delay in fetal aminopterin/methotrexate syndrome.

Del Campo M, Kosaki K, Bennett FC, Jones KL.

Teratology. 1999 Jul;60(1):10-2. Review.

PMID:
10413333
5.

[Effect of oral contraceptives on developmental anomalies and on the sex ratio of newborn infants].

Pejtsik B, Hadnagy J, Rappai G, Kóbor J.

Orv Hetil. 1990 Jun 3;131(22):1187-90. Review. Hungarian.

PMID:
2192336
6.

[Congenital anomalies in the central nervous system(1)diagnosis of fetal CNS anomalies].

Shirane R.

No Shinkei Geka. 2010 Dec;38(12):1133-43. Review. Japanese. No abstract available.

PMID:
21160107
7.
8.

Risks of statin use during pregnancy: a systematic review.

Kazmin A, Garcia-Bournissen F, Koren G.

J Obstet Gynaecol Can. 2007 Nov;29(11):906-8. Review.

PMID:
17977494
9.

Surgical treatment of central nervous system malformations.

Genitori L, Donati PA, Giordano F, Sanzo M, Mussa F, Sardo L, Spacca B, di Pietro G, Oliveri G.

Handb Clin Neurol. 2008;87:569-90. doi: 10.1016/S0072-9752(07)87031-X. Review. No abstract available.

PMID:
18809045

Supplemental Content

Support Center